Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,878 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
α(1)-Adrenoceptors in the urinary tract.
Yamada S, Ito Y. Yamada S, et al. Among authors: ito y. Handb Exp Pharmacol. 2011;(202):283-306. doi: 10.1007/978-3-642-16499-6_14. Handb Exp Pharmacol. 2011. PMID: 21290232 Review.
Bladder endothelin-1 receptor binding of bosentan and ambrisentan.
Osano A, Yokoyama Y, Hayashi H, Itoh K, Okura T, Deguchi Y, Ito Y, Yamada S. Osano A, et al. Among authors: ito y. J Pharmacol Sci. 2014;124(1):86-91. doi: 10.1254/jphs.13198fp. Epub 2013 Dec 27. J Pharmacol Sci. 2014. PMID: 24389822 Free article.
The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: bladder selectivity based on in vivo drug-receptor binding characteristics of antimuscarinic agents for treatment of overactive bladder.
Yoshida A, Fujino T, Maruyama S, Ito Y, Taki Y, Yamada S. Yoshida A, et al. Among authors: ito y. J Pharmacol Sci. 2010;112(2):142-50. doi: 10.1254/jphs.09r14fm. Epub 2010 Feb 4. J Pharmacol Sci. 2010. PMID: 20134113 Free article. Review.
11,878 results
You have reached the last available page of results. Please see the User Guide for more information.